RxDoctor Payments Data

Drew Winston

Infectious Disease · Los Angeles, CANPI 1265655203

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,160 of the $2,188 with a category attached, or 98.7%. Janssen Global Services, LLC accounts for 98.7% of it on its own, with 1 other manufacturer making up the rest.

$2,188in general payments, 2019–2025

Across 2 payments — averaging $1093.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Global Services, LLC$2K
  • Sobi, Inc$28
$694,329in research payments, 2019–2025

Across 57 payments — averaging $12,181 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$352K
  • Shire North American Group Inc$175K
  • Cidara Therapeutics, Inc.$98K
  • Janssen Research & Development, LLC$37K
  • Gilead$13K
  • Reviral, Inc.$13K
  • plus $7K from 1 others

What the payments were for

  • Consulting fees$2,16099%
  • Food & beverage$281%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Global Services, LLC1$2,160
Sobi, Inc1$28

How this compares

$2,188 in reported general payments places this provider in the 75th percentile of 856 infectious disease providers in California.

See all infectious disease providers in California →

Other infectious disease in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →